{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:37:43Z","timestamp":1785832663205,"version":"3.56.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3892\/mmr.2015.4062","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T10:38:44Z","timestamp":1436351924000},"page":"5179-5184","source":"Crossref","is-referenced-by-count":27,"title":["Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125"],"prefix":"10.3892","volume":"12","author":[{"given":"BRETT","family":"McKINNON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL D.","family":"MUELLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KONSTANTINOS","family":"NIRGIANAKIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NICK A.","family":"BERSINGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,7,8]]},"reference":[{"key":"key20180108021245_b1-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Eskenazi","year":"1997","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"Suppl 1","key":"key20180108021245_b2-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.pain.2007.07.006","article-title":"Pain and endometriosis","volume":"132","author":"Evans","year":"2007","journal-title":"Pain"},{"key":"key20180108021245_b3-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2003-41330","article-title":"Endometriosis and subfertility: Is the relationship resolved","volume":"21","author":"D'Hooghe","year":"2003","journal-title":"Semin Reprod Med"},{"key":"key20180108021245_b4-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.rct.0000176014.37051.c7","article-title":"Computed tomography findings of pathologically confirmed pulmonary parenchymal endometriosis","volume":"29","author":"Chung","year":"2005","journal-title":"J Comput Assist Tomogr"},{"key":"key20180108021245_b5-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0974-1208.44112","article-title":"Recognising, understanding and managing endometriosis","volume":"1","author":"Fraser","year":"2008","journal-title":"J Reprod Sci"},{"key":"key20180108021245_b6-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9378(15)30003-X","article-title":"Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity","volume":"14","author":"Sampson","year":"1927","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108021245_b7-mmr-12-04-5179","first-page":"151","article-title":"Retrograde menstruation in healthy women and in patients with endometriosis","volume":"64","author":"Halme","year":"1984","journal-title":"Obstet Gynecol"},{"key":"key20180108021245_b8-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9378(97)70550-7","article-title":"Cancer risk after a hospital discharge diagnosis of endometriosis","volume":"176","author":"Brinton","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108021245_b9-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1749-6632.2002.tb02788.x","article-title":"Role of endometriosis in cancer and tumour development","volume":"955","author":"Swiersz","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"key20180108021245_b10-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2008-1068762","article-title":"Cancer and endometriosis: Do we need to be concerned?","volume":"15","author":"Martin","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"key20180108021245_b11-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0895-4356(90)90160-Q","article-title":"Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer","volume":"43","author":"Gwinn","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"key20180108021245_b12-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"621","DOI":"10.5694\/j.1326-5377.2003.tb05387.x","article-title":"The efficacy of non-contraceptive uses for hormonal contraceptives","volume":"178","author":"Fraser","year":"2003","journal-title":"Med J Aust"},{"key":"key20180108021245_b13-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation - a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"key20180108021245_b14-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/aje\/155.3.217","article-title":"Infertility, fertility drugs, and ovarian cancer: A pooled analysis of case-control studies","volume":"155","author":"Ness","year":"2002","journal-title":"Am J Epidemiol"},{"key":"key20180108021245_b15-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: A case-control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br J Cancer"},{"key":"key20180108021245_b16-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.aje.a117296","article-title":"Parity, contraception, infertility, and the risk of epithelial ovarian cancer","volume":"140","author":"Risch","year":"1994","journal-title":"Am J Epidemiol"},{"key":"key20180108021245_b17-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0015-0282(16)57506-2","article-title":"Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis","volume":"63","author":"Ryan","year":"1995","journal-title":"Fertil Steril"},{"key":"key20180108021245_b18-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(00)01630-7","article-title":"Immunobiology of endometriosis","volume":"75","author":"Lebovic","year":"2001","journal-title":"Fertil Steril"},{"key":"key20180108021245_b19-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2005.12.010","article-title":"PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis","volume":"195","author":"Bersinger","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108021245_b20-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1447-0756.2006.00373.x","article-title":"Immunological factors and their role in the genesis and the development of endometriosis","volume":"32","author":"Siristatidis","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"key":"key20180108021245_b21-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13813455.2012.687003","article-title":"Analysis of cytokines in the peritoneal fluid of endometriosis patients as a function of the menstrual cycle stage using the Bio-Plex platform","volume":"118","author":"Bersinger","year":"2012","journal-title":"Arch Physiol Biochem"},{"key":"key20180108021245_b22-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/oxfordjournals.humrep.a137277","article-title":"CA-125 in peritoneal fluid from patients with endometriosis","volume":"6","author":"Moen","year":"1991","journal-title":"Hum Reprod"},{"key":"key20180108021245_b23-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0015-0282(16)54894-8","article-title":"CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis","volume":"57","author":"Koninckx","year":"1992","journal-title":"Fertil Steril"},{"key":"key20180108021245_b24-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00404-004-0645-7","article-title":"High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis","volume":"271","author":"Matalliotakis","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"key20180108021245_b25-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S1516-31802006000400010","article-title":"Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis","volume":"124","author":"Amaral","year":"2006","journal-title":"Sao Paulo Med J"},{"key":"key20180108021245_b26-mmr-12-04-5179","first-page":"301","article-title":"Development of an endometrial explant model for the investigation of uterine readiness for implantation in the human","volume-title":"Implantation in Mammals","author":"Bersinger","year":"1993"},{"key":"key20180108021245_b27-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejim.2006.12.001","article-title":"Role of tumour markers in patients with solid cancers. A critical review","volume":"18","author":"Duffy","year":"2007","journal-title":"Eur J Intern Med"},{"key":"key20180108021245_b28-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cncr.23577","article-title":"Combining a symptoms index with CA125 to improve detection of ovarian cancer","volume":"113","author":"Anderson","year":"2008","journal-title":"Cancer"},{"key":"key20180108021245_b29-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jcla.20323","article-title":"Cancer antigen 125 levels in inflammatory bowel diseases","volume":"23","author":"Ataseven","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"key20180108021245_b30-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"key20180108021245_b31-mmr-12-04-5179","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res"},{"key":"key20180108021245_b32-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180108021245_b33-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/IGC.0b013e31821a3726","article-title":"Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma","volume":"21","author":"Chang","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"key20180108021245_b34-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem"},{"key":"key20180108021245_b35-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108021245_b36-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br J Cancer"},{"key":"key20180108021245_b37-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/ijms12010627","article-title":"HE4 in the differential diagnosis of a pelvic mass: a case report","volume":"12","author":"Anastasi","year":"2011","journal-title":"Int J Mol Sci"},{"key":"key20180108021245_b38-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2012.03.011","article-title":"Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women","volume":"125","author":"Hallamaa","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180108021245_b39-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"590950","DOI":"10.1155\/2014\/590950","article-title":"Hormonal contraceptive use and the prevalence of endometriotic lesions at different regions within the peritoneal cavity","volume":"2014","author":"McKinnon","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20180108021245_b40-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/humupd\/4.5.719","article-title":"Paracrine changes in the peritoneal environment of women with endometriosis","volume":"4","author":"Kupker","year":"1998","journal-title":"Hum Reprod Update"},{"key":"key20180108021245_b41-mmr-12-04-5179","first-page":"CD008475","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Brown","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180108021245_b42-mmr-12-04-5179","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejogrb.2013.08.010","article-title":"Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment","volume":"170","author":"Nirgianakis","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.4062\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T20:04:20Z","timestamp":1599249860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.4062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,8]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,7,8]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3892\/mmr.2015.4062"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.4062","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,8]]}}}